Educational level and HIV disease progression before and after the introduction of HAART: A cohort study in 989 HIV seroconverters in Spain

Sexually Transmitted Infections

Volumn 87, Issue 7, 2011, Pages 571-576

  Monge, Susana ^a   Jarrín, Inmaculada ^a   Pérez Hoyos, Santiago ^b   Ferreros, Inmaculada ^c   García Olalla, Patricia ^d   Muga, Roberto ^e   Del Romero, Jorge ^f   Belda, Josefina ^g   Castilla, Jesús ^h   Bolúmar, Francisco ⁱ   Del Amo, Julia ^a  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b Research Institute   (Spain)

^c CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^d AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f CENTRO SANITARIO SANDOVAL   (Spain)

^g CIPS   (Spain)

^h CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

ⁱ UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; DISEASE COURSE; EDUCATIONAL STATUS; FEMALE; GENDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEROCONVERSION; SPAIN; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; DISEASE PROGRESSION; EDUCATIONAL STATUS; FEMALE; HIV INFECTIONS; HUMANS; MALE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SPAIN;

EID: 82555187989     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050125     Document Type: Article

References (29)

1. del Amo J, Pérez-Cachafeiro S, Hernando V, et al. ECDC Technical Report. Migrant Health: Epidemiology of HIV and AIDS in Migrant Communities and Ethnic Minorities in EU/EEA Countries. Stockholm, Sweden: European Centre for Disease Prevention and Control, 2009.
2. Moatti JP, Souteyrand Y. HIV/AIDS social and behavioural research: past advances and thoughts about the future. Soc Sci Med 2000;50:1519-32. (Pubitemid 30129127)
3. Dray-Spira R, Lert F. Social health inequalities during the course of chronic HIV disease in the era of highly active antiretroviral therapy. AIDS 2003;17:283-90. (Pubitemid 36223252)
4. Perez-Hoyos S, Ferreros I, del Amo J, et al. Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on. AIDS 2006;20:289-91.
5. Davey SG, Hart C, Hole D, et al. Education and occupational social class: which is the more important indicator of mortality risk? J Epidemiol Community Health 1998;52:153-60. (Pubitemid 28130169)
6. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health 1997;18:341-78. (Pubitemid 27194075)
7. Skalicka V, van Lenthe F, Bambra C, et al. Material, psychosocial, behavioural and biomedical factors in the explanation of relative socio-economic inequalities in mortality: evidence from the HUNT study. Int J Epidemiol 2009;38:1272-84.
8. Pensola T, Martikainen P. Life-course experiences and mortality by adult social class among young men. Soc Sci Med 2004;58:2149-70. (Pubitemid 38407028)
9. Strand BH, Groholt EK, Steingrimsdottir OA, et al. Educational inequalities in mortality over four decades in Norway: prospective study of middle aged men and women followed for cause specific mortality, 1960-2000. BMJ 2010;340:c654.
10. Lager A, Bremberg S, Vagero D. The association of early IQ and education with mortality: 65 year longitudinal study in Malmo, Sweden. BMJ 2009;339:b5282.
11. Huisman M, Kunst AE, Bopp M, et al. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. Lancet 2005;365:493-500. (Pubitemid 40215732)
12. Regidor E, de Mateo S, Calle ME, et al. Educational level and mortality from infectious diseases. J Epidemiol Community Health 2002;56:682-3.
13. CASCADE. Effect of ignoring the time of HIV seroconversion in estimating changes in survival over calendar time in observational studies: results from CASCADE. AIDS 2000;14:1899-906.
14. Jarrin I, Geskus R, Perez-Hoyos S, et al. (Analytical methods in cohort studies of patients with HIV infection). Enferm Infecc Microbiol Clin 2010;28:298-303.
15. Porter K, Johnson AM, Phillips AN, et al. The practical significance of potential biases in estimates of the AIDS incubation period distribution in the UK register of HIV seroconverters. AIDS 1999;13:1943-51. (Pubitemid 29509555)
16. Prentice RL, Kalbfleisch JD, Peterson AV Jr, et al. The analysis of failure times in the presence of competing risks. Biometrics 1978;34:541-54. (Pubitemid 9067879)
17. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
18. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multistate models. Stat Med 2007;26:2389-430.
19. del Amo J, Del Romero J, Barrasa A, et al. Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999. Sex Transm Infect 2002;78:255-60.
20. Schechter MT, Hogg RS, Aylward B, et al. Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care. J Clin Epidemiol 1994;47:59-67. (Pubitemid 24034291)
21. Junghans C, Low N, Chan P, et al. Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study. AIDS 1999;13:2547-54. (Pubitemid 30038033)
22. Borrel C, Regidor E, Arias LC, et al. Inequalities in mortality according to educational level in two large Southern European cities. Int J Epidemiol 1999;28:58-63. (Pubitemid 29086211)
23. Jarrin I, Lumbreras B, Ferreros I, et al. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART. Int J Epidemiol 2007;36:187-94. (Pubitemid 47061596)
24. Wood E, Montaner JS, Chan K, et al. Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS 2002;16:2065-72. (Pubitemid 35205271)
25. Borrell C, Rodriguez-Sanz M, Pasarin MI, et al. AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System? Eur J Public Health 2006;16:601-8. (Pubitemid 44899961)
26. Mari-Dell'olmo M, Rodriguez-Sanz M, Garcia-Olalla P, et al. Individual and community-level effects in the socioeconomic inequalities of AIDS-related mortality in an urban area of southern Europe. J Epidemiol Community Health 2007;61:232-40. (Pubitemid 46579559)
27. Falagas ME, Zarkadoulia EA, Pliatsika PA, et al. Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature. Retrovirology 2008;5:13.
28. Collazos J, Asensi V, Carton JA, et al. The influence of the patients' educational levels on socioeconomic, clinical, immunological and virological endpoints. AIDS Care 2009;21:511-19.
29. Zaragoza-Macias E, Cosco D, Nguyen ML, et al. Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population. AIDS Res Hum Retroviruses 2010;26:133-8.